With the help of genetic engineering technology, OX40L expression can be precisely up-regulated in antigen-presenting cells or T cells, thereby enhancing the costimulatory signal of OX40/OX40L axis, optimizing the activity of T cell subsets, and further improving the anti-tumor efficacy of cell therapy. The gene discussed is TNFSF4; the disease is neoplasm.